Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NUTX | Nutex Health, Inc. | 2025-12-02 08:00:14 | 126.99 | 7.41 | 6.2 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUTX | 0001479681 | Nutex Health, Inc. | US67079U3068 | — | 113363609 | Nasdaq | 7389 | Services-Business Services, NEC | 1231 | DE | 6030 S. RICE AVE. | HOUSTON | TX | 77081 | UNITED STATES | US | (713) 660-0557 | 6030 S. RICE AVE., HOUSTON, TX, 77081 | 6030 S. RICE AVE., HOUSTON, TX, 77081 | Clinigence Holdings, Inc. | — | — | Thomas Vo | — | http://nutexhealth.com | 18,200,000 | 6,905,262 | 7,071,916 | Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas. | 2025-11-27 17:11:26 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 18,200,000 | -127,000,000 | -87.4656 | 5,950,539 | -739,476,320 | -99.2017 |
| 2023 | 145,200,000 | -888,800,000 | -85.9574 | 745,426,859 | 94,500,734 | 14.5179 |
| 2022 | 1,034,000,000 | 947,750,000 | 1,098.8406 | 650,926,125 | 602,481,146 | 1,243.64 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Joshua Detillio | Chief Operating Officer | 2024 | 434,808 | 297,500 | — | — | 43,931 | 810,664 |
| Thomas T. Vo | Chief Executive Officer | 2024 | 557,692 | 500,000 | — | — | 23,522 | 1,162,214 |
| Warren Hosseinion | President | 2024 | 755,100 | 377,500 | — | — | 49,669 | 1,243,432 |
| Jon Bates | Chief Financial Officer | 2024 | 324,677 | 275,000 | — | — | 53,155 | 682,578 |
| Warren Hosseinion | President | 2023 | 711,537 | 0 | — | — | 24,489 | 736,026 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 800 |
| 2023 | 800 |
| 2021 | 24 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 479,948,633 | 247,646,316 | 219,294,306 |
| Cost Of Revenue | — | — | — |
| Gross Profit | 196,261,277 | 34,774,171 | 13,452,382 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 41,923,972 | 33,229,718 | 18,030,832 |
| Operating Expenses | 65,563,477 | 66,547,919 | 420,051,536 |
| Operating Income | 130,697,800 | -31,773,748 | -406,599,154 |
| Net Income | 52,096,040 | -45,786,614 | -424,780,446 |
| Earnings Per Share Basic | 10.23 | -0.07 | -0.67 |
| Earnings Per Share Diluted | 9.69 | -0.07 | -0.67 |
| Weighted Average Shares Outstanding Basic | 5,090,787 | 661,247,959 | 634,877,629 |
| Weighted Average Shares Outstanding Diluted | 5,491,676 | 654,094,485 | 634,000,665 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 40,640,616 | 22,002,056 | 34,255,264 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 4,300,000 | 58,624,301 | 57,777,386 |
| Inventories | 2,849,814 | 3,390,584 | 3,533,285 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 248,897,473 | — | — |
| Total Assets Current | 292,478,885 | 90,848,403 | 97,973,924 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 77,932,744 | 81,387,649 | 82,094,352 |
| Other Assets Non Current | — | 33,089,636 | 24,500 |
| Total Assets Non Current | 362,841,508 | 307,397,094 | 333,778,061 |
| Total Assets | 655,320,393 | 398,245,497 | 431,751,985 |
| Accounts Payable | 9,613,821 | 18,899,196 | 23,614,387 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 14,395,457 | 10,808,721 | 12,546,097 |
| Other Liabilities Current | 110,531,725 | 6,364,586 | — |
| Total Liabilities Current | 154,226,190 | 58,313,052 | 54,862,969 |
| Long Term Debt | 22,465,896 | 26,314,733 | 23,051,152 |
| Other Liabilities Non Current | 312,562,391 | — | — |
| Total Liabilities Non Current | 11,768,239 | 12,959,171 | 15,019,633 |
| Total Liabilities | 466,788,581 | 319,139,391 | 311,424,585 |
| Common Stock | 5,511 | 676,680 | 650,224 |
| Retained Earnings | -356,976,499 | -409,072,539 | -363,285,925 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 132,437,993 | 61,453,190 | 95,862,701 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 18,971,972 | 17,591,572 | 13,131,374 |
| Share Based Compensation Expense | 16,300,000 | 935,967 | 189,581 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 173,956,924 | 969,761 | -56,622,133 |
| Change In Inventories | -540,770 | -142,701 | 719,107 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 3,539,372 | -4,715,101 | 10,018,100 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 23,153,807 | 1,256,452 | 50,607,108 |
| Purchases Of Marketable Securities | 2,940,796 | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 2,303,897 | 9,496,832 | 14,632,414 |
| Acquisition Of Business | 0 | 703,893 | — |
| Other Investing Activities | 2,665,222 | — | — |
| Cash From Investing Activities | -5,606,018 | -11,239,882 | -4,337,398 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 9,202,500 | 5,400,000 | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 2,079,390 | 1,592,714 | 72,055 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 1,090,771 | -2,269,778 | -48,132,730 |
| Change In Cash | 18,638,560 | -12,253,208 | -1,863,020 |
| Cash At End Of Period | 40,640,616 | 22,002,056 | 34,255,264 |
| Income Taxes Paid | 798,990 | 849,358 | 8,233,000 |
| Interest Paid | 3,471,708 | 1,639,044 | 4,622,106 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 10.23 | -0.07 | -0.67 |
| Price To Earnings Ratio | 3.0978 | -385.6957 | -425.3519 |
| Earnings Growth Rate | -14,714.2857 | -89.5522 | 81.0811 |
| Price Earnings To Growth Ratio | -0.0002 | 4.3069 | -5.246 |
| Book Value Per Share | 37.0339 | 0.1196 | 0.1895 |
| Price To Book Ratio | 0.8557 | 225.6821 | 1,503.6568 |
| Ebitda | 91,799,017 | -11,027,815 | -390,925,812 |
| Enterprise Value | 157,547,777.03 | 17,867,956,668.6533 | 180,932,450,987.668 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.2783 | 0.6041 | 0.3713 |
| Capital Expenditures | 15,517,067 | 16,884,869 | 95,210,791 |
| Free Cash Flow | 7,636,740 | -15,628,417 | -44,603,683 |
| Return On Equity | 0.3934 | -0.7451 | -4.4311 |
| One Year Beta | 1.3533 | 0.9962 | 2.1657 |
| Three Year Beta | 1.7209 | 1.2483 | 1.1676 |
| Five Year Beta | 1.1514 | 1.1419 | 1.167 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Bates Jon Christian | Chief Financial Officer | 2025-11-25 | 750 | A | 5,638 |
| Bates Jon Christian | Chief Financial Officer | 2025-04-08 | 1,000 | A | 4,888 |
| Spears Kelvin | Director | 2025-04-04 | 34 | D | 31,992 |
| Luqman Elisa V | Chief Legal Officer - SEC | 2025-04-04 | 266 | D | 1,070 |
| Hosseinion Warren | Director, President | 2025-04-04 | 1,072 | D | 3,422 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 1,527,276 | 14,782 | 103.32 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 103 | 1 | 103 |
| PharVision Advisers, LLC | 2025-09-30 | 419,686 | 4,062 | 103.32 |
| GOLDMAN SACHS GROUP INC | 2025-09-30 | 3,042,464 | 29,447 | 103.32 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2025-09-30 | 368,749 | 3,569 | 103.32 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 5 | 516.6 | 0.0077 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 5 | 516.6 | 0.0077 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 5 | 516.6 | 0.0077 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYRHX | 8 | 826.56 | 0.0067 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYROX | 8 | 826.56 | 0.0067 |